Read September 2026SurpassMD review
Two discounts, one headline
The $114 is an introductory code price on a twelve-month supply.
What SurpassMD charges, and what it bills
One row per molecule and delivery route. Where the two figures differ, the struck number is what SurpassMD leads with and the figure under it is what a buyer cannot get below. Both are published by the seller; neither is a walked checkout.
| Product | Per month | 6 months | As the dose rises |
|---|---|---|---|
| Semaglutide, injectionRead September 2026The seller does not state what happens as the dose rises. | $1,314 | The seller does not state what happens as the dose rises. | |
| Tirzepatide, injectionRead September 2026The seller does not state what happens as the dose rises. | $1,854 | The seller does not state what happens as the dose rises. |
- Semaglutide, injection: The $114 headline is the introductory price on the twelve-month supply; the same table prices a 30-day supply at $219 at the standard renewal rate, with $175 introductory, and the footnote makes the introductory column a discount-code price on the first subscription. Six months comes to $1,314 rather than $684, a difference of $630.
- Tirzepatide, injection: The $177 headline is the introductory twelve-month rung; the 30-day row of the same table is $309 at the standard renewal rate and $247 introductory. Six months comes to $1,854 rather than $1,062, a difference of $792.
The 6-month column is the billed monthly figure multiplied by 6. It is arithmetic on published prices, not a forecast of a bill: a real six months also carries dose changes, labs and shipping, and those are covered below where SurpassMD states them.
The bottom line
SurpassMD leads with $114 a month. That is the introductory rate on the twelve-month supply. A 30-day supply at the standard renewal rate is $219. Tirzepatide is $309 on the same row.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
What the figure does not cover
Fees, terms and cancellation at SurpassMD
- Outside the headline
- No membership or provider fee is published beside either injectable figure.
- Prepay
- Three, six and twelve-month supplies are priced at $195, $180 and $143 a month at the standard rate. Each is a supply term, and the table gives no refund terms for one already paid.
- Shipping
- Cold-chain shipping is stated as part of the plan price.
Pricing transparency
How SurpassMD publishes its prices
The semaglutide table carries four supply terms. A 30-day supply is $219 at the standard renewal rate. Three months is $195, six months $180, twelve months $143. The introductory column beside them reads $175, $156, $144 and $114. Its footnote makes that column a discount-code price applied to the first subscription. Tirzepatide runs $309, $299, $275 and $222 standard. The oral tablet publishes $183 as an introductory price with no standard figure beside it.
At a glance
- Category
- GLP-1 sellers by price
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 51
- From
- $219/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 50 states and DC
The seller
What SurpassMD is
SurpassMD sells compounded semaglutide and compounded tirzepatide by injection. An oral semaglutide tablet sits beside them. Licensing is stated across 50 states and DC. Each injectable line publishes a four-row pricing table.
How it works
An online assessment starts it. A licensed provider reviews the history and decides. The plan figure covers provider review, medication, cold shipping and ongoing support. No separate membership charge is published beside either rate.
Branded or compounded
Both injectables are compounded preparations. A compounded drug is not FDA-approved. The agency does not review it before dispensing. The site describes 503A compounding and cold-chain handling.
Where the money holds, and where it moves
Predictable
- A four-row supply table on each page
- Standard rate printed beside the introductory one
- One price stated at every prescribed dose
- Licensed in 50 states and DC
Moves, or is not stated
- The headline stacks a code and a prepay
- Month-to-month semaglutide is $219, not $114
- The oral tablet publishes no standard rate
- Tirzepatide month to month is $309
Who this is worth it for
Buyers who will read the four-row table under the headline figure.
Who should price elsewhere
Anyone budgeting from $114 without a discount code and a year.
Priced against
Sellers to price beside SurpassMD
MyFastRxBuyers who want the standing rate stated beside the introductory one
See MyFastRx →
Mint MedBuyers who want a rate that does not move as the dose climbs
See Mint Med →
Ozari HealthBuyers who have never taken a GLP-1 and can pay a quarter in advance
See Ozari Health →
More GLP-1 sellers by price priced end to end: TelePeptideTeleSlim ClinicTell Her DocTelos RxThe Aesthetic ConciergeThe Edit
Sponsored alternative
Bodybuilding Health+
Buyers who want to start without committing a year of money
Check Bodybuilding Health+ availability →Frequently asked
Is $114 a monthly rate?
What does tirzepatide cost month to month?
Does the price rise as the dose rises?
What is published for the oral tablet?
Is SurpassMD legit?
Is SurpassMD expensive compared with other GLP-1 sellers by price providers?
Or go back to the price desk and compare SurpassMD against every seller on it.